Tech Company Financing Transactions
Nutcracker Therapeutics Funding Round
Arch Venture Partners and private investors participated in a $167 million Series C funding round for Nutcracker Therapeutics. The round was announced on 3/14/2022.
Arch Venture Partners (Lead Investor) (Robert Nelsen)
Emeryville, CA 94608
Browse more venture capital transactions:
Prev: 3/14/2022: Gauntlet venture capital transaction
Next: 3/14/2022: SupPlant venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs